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TECHNIC OF ASSAY OF AN UNKNOWN STEROID FOR POSSIBLE
LOCAL ACTIVITY IN THE SKIN OF MAN
LEON GOLDMAN, M.D., RICHARD FLATT, M.D., AND JEANNE BASKETT, B.S.
With the rapid advances in the field of steroid chemistry and the syntheses of
new products, it becomes necessary to have clinical assay technics for evaluation
of these new materials. In a discussion of criteria for bio-assay of hormones,
Segaloff (1) has listed the following requirements to be met by the ideal assay.
1. Specific
2. Reproducible from laboratory to laboratory
3. Sensitive
4. Statistically sound
5. Simple
6. Rapid
7. Inexpensive
Except perhaps for specificity (as regards a certain steroid), these requirements
may apply equally well to the development of technics for the detection of local
activity of the corticosteroids. We believe that such an assay should be done in
the skin of man, not animals, and should require only small amounts of these
new and very precious compounds. The decision to discard a compound or to do
more detailed experiments with this compound or group of compounds, is of
extreme practical importance.
To assist in the elaboration of such technics, we have used the following pro-
gram of progressive steps of development, after we have received the steroid
from the research chemist and after the initial performance of animal studies for
toxicity. It is important to emphasize that we are concerned with attempts to
study these compounds at the local or cellular level. Furthermore, such studies,
though primarily for assay, may help us to understand the possible mechanism of
the local action of these steroids, for Pincus and Hechter (2) have indicated that
because of the great interest in these compounds, the problem of such mechanisms
has been taken out of the academic field. The skin of man appears more easily
suitable to these clinical assay studies than does the eye of man or the joint
cavity. As yet, it is not practical to use the nasal mucosa or tissue cultures. The
local activity of cortisone in the eye and the failure of local activity of this
steroid in the skin of man is well known, and lends support to the argument for
the utilization of easily available human skin. The differences of reaction of the
steroid locally in the skin of man as compared to the skin of animals (cytologic
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CHART No. 1. Showing the phases of assay technics
changes, granulation tissue, etc.), further emphasizes the need for these studies
to be done in man.
In general, the technic of assay includes the following steps in order.
1. estimation of solubility (and or absorbability) in the skin
2. attempts to block, in a more or less standardized fashion, controlled local
inflammations
3. controlled clinical experiments with local injections and various types of
topical medications
It is the problem for the steroid chemist with his knowledge of the field to de-
termine what formula is to be presented to clinical investigators. Further know!-
edge on the conversion of steroids in tissue will help him to decide which com-
pounds to select. Most of the compounds now available for clinical assay appear
to be derivatives of hydrocortisone.
We must then receive approval from the toxicologist that the materials we are
to inject into the tissues of man, in the dosage range selected, are not toxic.
Then, sterile material is suspended in a suitable vehicle. If this is a vehicle
which we have not worked with before, then controls must be done with the
vehicle. We can proceed with the initial investigative studies with as little as 50
mgs. of an unknown material.
The suspension is injected superficially in the skin of man as an average dose
of 2.5 mgs. If this material is relatively insoluble, it must be mixed well and
agitated before injection. The local effect of this injection is recorded as regards
pain on injection, degree of inflammation, presence or absence of necrosis and
duration of the local reaction.
At the end of 24 hours usually, (or sooner, if the material is very soluble in
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tissue), a biopsy is taken and one half may be examined in frozen section for
crystals and for assay technics, and one half after paraffin embedding and
hematoxylin-eosin staining, may be examined for the hematoxylinophilic masses
which we have reported (3). Fixation in formaldehyde is preferred to fixation in
Helly's to bring out these basophilic masses. Detailed histoehemical studies, as
to the analysis of these masses, are being continued under the direction of
Atkinson (4). Most of the present histochemical studies have been done with
hydrocortisone acetate. With this corticosteroid, the mass appears within 24
hours. The mass is made up of desoxyribonucleic acid from the break down of
tissue cells bordering the injected site and in the direct area of injection from
unidentified mucopolysaccharides, probably of ground substance origin. Hema-
toxylinophilic masses have been found so far in all of the compounds, in which we
have detected some clinical evidence of local activity. Clinically, such areas re-
sulting from the injection of some of less soluble compounds are revealed as
atrophic zones which may last for some time depending on the solubility of the
injected material. With hydrocortisone acetate, the atrophic portion assumes a
poikilodermatous appearance.
With the frozen section technic (5), the location, size and character and per-
sistency of the crystals may be studied. With the red variable Polaroid color
filter (Polaroid Corporation), we believe these crystals can be observed more
clearly than under ordinary polarized light and can be photographed with
greater contrast.
As further studies of the solubility in tissue, we have employed, with additional
biopsies, the Porter-Silber colorimetric assay of material from the site of local
injection (6). Recently, paper chromatography has been done with skin over
which corticosteroids have been rubbed and into which corticosteroids have been
injected. This technic also has given additional proof of solubility in tissue by
the persistence or disappearance of the material after injection. In order to learn
more of the mechanisms at the cellular level, we have also been interested to
know if we can detect other steroids which may be formed locally in the skin
after injection of a certain steroid. With the small quantities which are available
for paper chromatography after the removal of skin biopsies, it has not been
possible as yet to show the conversion of the compound injected. These experi-
ments on paper chromatographed are being continued. Our studies of solubility
in the skin or absorbability from the skin, are similar to those of Wilson, Glynn,
Scull, McEwen and Ziff (7) using the synovial cavity in rheumatoid arthritis.
Additional studies are being done in the skin to determine the effect of various
enzyme systems on the steroids injected.
With the first step of the assay, we have determined that material is either
absorbed rapidly, slowly or not at all. If it is absorbed too rapidly, no local effect
may be produced, or the changes may be too rapid to observe (8).
Following these preliminary experiments, we do the studies of "controlled"
inflammation in the skin. We have used numerous materials to attempt to
produce an uniform tuberculin type of inflammatory response. We have used
tuberculin, Frei antigen, mosquito extracts, dust extracts, histoplasmin, tn-
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chophyton and oidiomycin. So far, oidiomycin has proved to be the most
practical, most "reproducible" and "safe." 0.1 cc of a 1:300—1:500 stock material
of oidiomycin is used. At present, we are using oidiomycin (Hollister-Stier Lab.).
The patient's response is first determined. The skin reaction for our present
dosage of steroid for local inhibition should range oniy from 5 to 10 millimeters.
Reactions which are severe may reveal no recognizable inhibition.
Following the determination of concentration of oidiomycin to be used, the
following tests are done, usually on the forearm in order proximally:
(1) oidiomycin + hydrocortisone acetate—2.5 mgs. (as standard)(2) oidiomycin + unknown steriod (same vehicle and concentration as
hydrocortisone acetate)
(3) oidiomycin control
The inhibition at 48 hours is measured and compared with hydrocortisone acetate
as the control inhibitor.
Next, we employ the direct intra-lesional injection (usually 2.5 mgs.) into a
patch of psoriasis. A disappearance of psoriasis in the area of injection, beginning
2—3 days after injection and definite at the end of 1st week, is a strong presump-
tuous evidence of local activity in the skin of man. Of all our preliminary clinical
testing, this has been the one test easiest to read and most constant in response.
With some soluble steroids, the inhibition of inflammation may develop earlier,
and may be transient but it does occur.
Only after the experiments listed above, do we go ahead with the study of
topical applications. This form of use, Sulzberger (9) has called, aptly, the very
practical aspect of local corticosteroid therapy. Since this phase of study demands
relatively large amounts of expensive materials, one must have some prior data
to warrant such expenditures. Therefore, this portion of the study follows the
other phases.
There appears to be two parts to the topical medication assay program.
1. composition of topical medication-concentration; vehicle
2. selection of patients for critical assay studies as opposed to the use of
patients in routine clinical surveys
The type of base for the steroid ointment is important. It is possible that the
reason for some of our initial inconstant results with hydrocortisone ointment
was due to the bases which we employed in the therapy of certain dermatoses.
In our experience, a base of mineral oil, white vaseline and lanolin was more
constantly effective than a base of the polyethylene glycol type. As Sulzberger
(10) has indicated, however, sometimes the reverse is true. Sometimes in certain
dermatoses, more lubrication is desired and so the lanolin type is used. It is
recommended then that for assay purposes, two types of ointment base be
employed. In our experiences, lotions are also effective but these need not be
considered in the initial assay program. Moreover, antibiotics and chemo-
therapeutic agents should not be added to the medications employed in these
preliminary studies. Control vehicles should always be used. We believe that the
actual clinical investigator and also the patient should not be aware which is
the control base and which is the active ointment.
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TABLE 1
Showing the detailed summaries of the testing of various compounds, for local activity in the
skin of man
COMPOUND
EFFECT OF LOCAL INJECTION_______
VALUE OF
TOPICAL
APPLICATION
HEMATOXY-
LINOPHILIC
MASSES
SOLUBILITY a
ADSORBABILITY
INHIBITION OF
TUBERCULIN TYPE
OF INFLAMMATORY
RESPONSE
INHIBITION
OFPSORIASIS
PATCH
CORTISONE + + A::ption o o o
CORTISONE
T RI CAR BA L LYLAT E
+ No Data 0 0 No Data
HYDROCORTISONE
FREE ALCOHOL 0
Rapidly
Absorbed 0 No Data
HYDROCORTIS ONE
FREE ALCOHOL
TYPE_B
+ Absorbod + + +
HYOROCORTISONE
ACETATE
Slow
Absorption + + +
HYDRO CORTISONE
ALPHA EPIMER f No Data 0 0 No Data
jj3Jc41o5
No Data 0 0 No Data
SC 5142
t5cCg185
Slow
Aboorptioo
+ OeIayOd + No Data
DESOXY-
CORTICOSTERONE 0 No Data 0 0 No Oato
CHOLESTEROL 0 No Dots 0 0 No Dots
ESTRADIOL 0 No Doto 0 0 No Data
PREGNENOLONE 0 No Data 0 0 No Data
TESTOSTERONE
ACETATE 0 No Data 0 0 0
SC 3669
0%_COO OH
(sever: No Data No Data No Data No Data
Care must be exercised in choosing patients for the initial critical assay studies.
If the inflammation in the skin is too severe, it may not be able to be blocked.
In common, with the clinical testing of other dermatological preparations, efforts
should be made to minimize the influence of suggestion. Witten et al (11) have
indicated, and we have found, the best testing subject is infantile eczema pa-
tient, subacute phase without secondary infections. Better control studies are
accomplished with the hospitalized infant. Selective areas can be used with
control bases on other areas. Another group which can be used, is the group of
eczematous dermatitides of the hands and face, chiefly of the eczematous contact
type of moderate severity. Rein (12) has also indicated the value of this group.
Improvement is produced by the ointment in 48 hours. Following the use of these
selected groups for clinical testing, various other conditions may be tried for
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routine therapy such as pruritus ani, seborrheic dermatitis and atopic dermatitis,
etc. At this stage of the clinical testing, also different concentrations may be
tried and also different types of topical medications, such as lotions. At this stage
also intra lesional injections into cutaneous lymphoblastomas, localized neuro-
dermatitis, localized scleroderma, sarcoidal lesions, discoid lupus erythematosus
may be tried. For local injections into such hard lesions as keloids and Peyronie's
Disease (Wayman) (13), we have employed the suspension of the steroid put up
in a glass cartridge form or in the metapule for injection with the Hypospray jet
injection apparatus.
How have these theoretical considerations been borne out? Table 1 shows
some of our findings in the assay of various types of materials. So up to the
present, only hydrocortisone, one type of free alcohol and the acetate, have
shown the correlation of the positive reports of the preliminary testing with
the later positive clinical reports. Today, therefore, just as hydrocortisone is
the corticosteroid of preference for systemic administration, so it is the cortico-
steroid preferred for local use in and on the skin.
These technics are offered then only as a suggestion for preliminary testing
before a steroid is recommended for routine clinical use. Future developments
will modify and better these technics, for we would agree with Gaddum (14)
that "the time has not yet come when the physician is justified in accepting the
estimate of hormones without a critical consideration of the methods by which
these estimates have been obtained."
CONCLUSIONS
A technic of bio-assay is described in which quantities as little as 50 mgs. of a
new unknown steroid can be evaluated as to potential local effect in the skin of
man. Only after these preliminary experiments, should the more extensive and
expensive detailed clinical studies be initiated, first, with controlled critical
studies with injections and topical applications, and then routine clinical surveys.
In our experience, only hydrocortisone free alcohol and hydrocortisone acetate
have shown the correlation of the preliminary assay technic, and the subsequent
clinical value for local activity in the skin of man.
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